Pressure BioSciences Sells Remaining Stake in Source Scientific | GenomeWeb
NEW YORK (GenomeWeb News) — Pressure BioSciences today said it has received $1.8 million for selling its Source Scientific subsidiary to two individuals, Richard Henson and Bruce Sargeant.
 
PBI had originally received $1.2 million, which comprised a repayment of aggregate principal and promissory notes stemming from a 2004 agreement under which Sargeant and Henson bought 70 percent of Source Scientific.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.